2018 Cancer Survivors Day at Providence Saint John’s Health Center

  • Jun 3, 2018
  • 1:00 PM - 4:00 PM

On National Cancer Survivors Day we celebrated living, learning and growing … with yoga, Qi Gong, therapeutic art, massage, meditation, healthy cooking and more!

Associates for Breast and Prostate Cancer Studies – Mother’s Day Luncheon

  • May 9, 2018
  • 10:30 AM - 2:00 PM

The ABCs Mother’s Day Luncheon raised money to benefit breast and prostate cancer research at the John Wayne Cancer Institute at Providence Saint John’s Health Center.

Glioblastoma: Prognosis Treatment & Standard of Care

Glioblastoma is a cancer of the brain that’s difficult to treat because it invades the normal brain structure. Hear about the current and future treatment options for this deadly disease from Santosh Kesari M.D., Chair of Translational Neurosciences & Neurotherapeutics.

Early loss of Histone H2B monoubiquitylation alters chromatin accessibility and activates key immune pathways that facilitate progression of ovarian cancer

Dave S.B. Hoon, Ph.D., Professor and Director of Dept. of Translational Molecular Medicine in collaboration with the University of Pennsylvania have published a new article in Cancer Research Journal.

UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive Tumors

Dave S.B. Hoon, Ph.D., Professor and Director of Dept. of Translational Molecular Medicine and his team have published a new article in Cell Journal.

Podcast: Making Advances in Breast Cancer Treatment Options

Listen to the podcast by Meet The Doctors, featuring Janie Grumley, M.D., FACS, Associate Professor of Surgery, Director, Comprehensive Breast Program, Margie Petersen Breast Center at Providence Saint John’s Health Center to learn about her novel approach to breast cancer surgery with use of advance oncoplastic surgery and intra-operative radiation therapy to remove tumors.

The Future of Cancer Treatment

What role does clinical research play in medicine? Dr. Steven O’Day, joins host Julie Alexandria on the Future of Health radio to discuss Immunotherapy: The Future of Cancer Treatment.

Lipid–Polymer Hybrid Nanoparticles as a Next-Generation Drug Delivery Platform: State of the Art, Emerging Technologies, and Perspectives

Learn about Lipid–polymer hybrid nanoparticles (LPHNPs) and the recent key advancements for future clinical possibilities, from Venkata Yenugonda, M.Phil, Ph.D., Associate Professor, Department of Translational Neurosciences & Neurotherapeutics, and Director, Drug Discovery and Nanomedicine.